Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot2 - STU 1 ballot
Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot2 - STU 1 ballot
Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
version: 12; Last updated: 2023-12-06 16:50:59+0000
Profiles: ComparativeEvidence, SingleStudyEvidence
ArtifactPublicationStatus: Active
url: https://fevir.net/resources/Evidence/47759
identifier: FEvIR Object Identifier/47759
name: ComparativeEvidence_Mean_difference_in_HbA1c_between_Surgery_and_Medical_Lifestyle_groups_in_Cummings_2016
title: ComparativeEvidence: Mean difference in HbA1c between Surgery and Medical/Lifestyle groups in Cummings 2016
status: Active
date: 2022-05-29 11:01:56+0000
author: Brian S. Alper:
publisher: Computable Publishing LLC
contact: support@computablepublishing.com
| Code | Value[x] |
| Evidence Based Medicine on FHIR Implementation Guide Code System evidence-communication: Evidence Communication | ComparativeEvidence |
| Evidence Based Medicine on FHIR Implementation Guide Code System evidence-communication: Evidence Communication | SingleStudyEvidence |
copyright:
https://creativecommons.org/licenses/by-nc-sa/4.0/
relatesTo
type: Derived From
relatesTo
type: Cite As
target:
ComparativeEvidence: Mean difference in HbA1c between Surgery and Medical/Lifestyle groups in Cummings 2016 [Evidence]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 47759. Revised 2022-05-29. Available at: https://fevir.net/resources/Evidence/47759. Computable resource at: https://fevir.net/resources/Evidence/47759.
description:
Mean HbA1c at 12 months in Cummings 2016 was 6.4% in Surgery group (n = 15) and 6.9% in Medical/Lifestyle group (n = 17), mean difference -0.50% (95% CI -1.52% to 0.52%)
variableDefinition
description:
32 patients aged 25 to 64 with T2DM and BMI between 30-45
variableRole: Population
observed: Cummings 2016 Trial Enrollment Group
variableDefinition
description:
Roux-en-Y Gastric Bypass vs. medical treatment (Intensive lifestyle and medical intervention ILMI)
variableRole: Exposure
comparatorCategory: medical treatment
observed: GroupAssignment: Roux-en-Y gastric bypass vs. medical treatment
variableDefinition
description:
HbA1c at 12 months
variableRole: Outcome
observed: OutcomeVariable: HbA1c at 12 months
synthesisType: not applicable
studyDesign: randomized assignment
statistic
description:
mean difference -0.50% (95% CI -1.52% to 0.52%)
note:
Mean HbA1c at 12 months in Cummings 2016 was 6.4% in Surgery group (n = 15) and 6.9% in Medical/Lifestyle group (n = 17)
statisticType: Mean Difference
quantity: -1 % (Details: UCUM code% = '%')
SampleSizes
NumberOfParticipants KnownDataCount 32 32 AttributeEstimates
Description Type Level Range 95% CI -1.52% to 0.52%
Confidence interval 0.95 -1.52-0.52 %
IG © 2024+ HL7 International / Clinical Decision Support. Package hl7.fhir.uv.ebm#1.0.0-ballot2 based on FHIR 6.0.0-ballot3. Generated 2025-09-04
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change